Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2024-01-03 00:00:00 ET · period of report 2024-01-02 · accession 0001420506-24-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-03 | 2024-01-02 | ROIV | Ramaswamy Vivek | 10% | S - Sale | $11.05 | -3.00M | 51.93M | -5% | -$33.15M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-01-02 | S | D | 3,000,000 | $11.05 | 51,929,426 | D | — | — | (F1) Reflects an award of restricted stock covering Common Shares that is fully vested. |